IGF::OT::IGF Development & Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorcer. NIDA Ref. No. N01DA-16-8926; POP: 09/18/2016 - 09/17/2021.

Murty Pharmaceuticals, Inc., Lexington KY

Investigators

Abstract

Management of New Project Tasks: As an incumbent contractor, MPI offers experience for the management of new project tasks. Preformulation Studies I: The investigations in this task will identify potential formulation/analytical challenges and/or development strategies. Preformulation Studies II: The investigations will assist in the selection of appropriate excipients and provide insight into potential incompatibilities for the drug products. Dosage Form Development Studies: Formulation studies will result in the appropriate design of useful preclinical and clinical formulations.